DMT: The Best Longevity Protocol?

In this solo episode, the All-In team tackles one of the most provocative topics in biohacking and longevity science: DMT as a potential life extension protocol. Chamath, Jason, Sacks, and Friedberg dive deep into the intersection of psychedelic research and modern medicine, examining whether DMT could play a role in extending human healthspan and lifespan.

The conversation begins with the hosts contextualizing DMT within the broader longevity landscape. They discuss existing longevity protocols like fasting, exercise, and supplementation, before pivoting to more unconventional approaches involving psychedelics. The hosts acknowledge the growing body of research suggesting that compounds like DMT may have neuroprotective properties and could influence aging at the cellular level.

Throughout the episode, the four investors apply their business and investment lens to the psychedelic research space. They explore which companies and researchers are making meaningful progress in understanding DMT's mechanisms and potential therapeutic applications. The discussion balances scientific rigor with the reality that much of the current evidence remains anecdotal, with many biohackers reporting subjective benefits from DMT use.

A significant portion of the conversation addresses the regulatory and cultural barriers to psychedelic research. The hosts debate whether current FDA frameworks are inhibiting potentially life-saving discoveries and discuss the economic opportunities in the emerging psychedelic medicine space. They also touch on the philosophical implications of pursuing longevity through unconventional means.

The episode features the Eight Sleep partnership, with the hosts discussing how sleep optimization forms the foundation of any serious longevity protocol. They explain how Eight Sleep's Pod technology maintains optimal sleep temperatures and uses Autopilot to personalize sleep conditions throughout the night. The hosts emphasize that while DMT and other interventions generate headlines, fundamental sleep quality often gets overlooked as a primary driver of healthspan.

The four investors also explore the psychological and spiritual dimensions of DMT use, moving beyond purely physiological longevity metrics. They consider how cognitive health, mental clarity, and psychological resilience factor into overall human longevity. The discussion acknowledges that longevity science has traditionally focused on physical markers, but emerging research suggests mental health may be equally critical.

Throughout the episode, the hosts maintain their characteristic blend of serious analysis and skeptical questioning. They ask hard questions about study methodology, potential biases in psychedelic research advocacy, and the distinction between genuine scientific breakthroughs and trendy biohacking fads. By episode's end, the team concludes that while DMT warrants further serious research, it should be considered as part of a comprehensive longevity strategy that prioritizes fundamentals like sleep, exercise, and nutrition first.